(Q33940268)

30 July 2017

1 reference

title

Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology (English)

1 reference

30 July 2017

1 reference

Hypericum perforatum

1 reference

P J Nathan

1

1 reference

PubMed ID

11277608

30 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Journal of Psychopharmacology

30 July 2017

1 reference

30 July 2017

15

1 reference

30 July 2017

1

1 reference

30 July 2017

47-54

1 reference

Independent regulation of beta 1- and beta 2-adrenoceptors

30 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Inhibition of MAO by fractions and constituents of hypericum extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Hyperforin as a possible antidepressant component of hypericum extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Depression, stress and immunological activation: the role of cytokines in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Clorgyline displays high affinity for sigma binding sites in C57BL/6 mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Harmless herbs: a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Effect of repeated treatment with electroconvulsive shock (ECS) on serotonin receptor density and turnover in the rat cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Low plasma GABA is a trait-like marker for bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Indinavir concentrations and St John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Depression: a new animal model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Inhibition of serotonin uptake into mouse brain synaptosomes by ionophores and ion-channel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Effects of repeated electroconvulsive shock on serotonin1A receptor binding and receptor-mediated hypothermia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Inhibition of monoamine oxidase by hypericin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Modulation of cytokine expression by hypericum extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

The validity of animal models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Second thoughts about safety of St John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500109

Pharmacokinetics of Hypericin and Pseudohypericin after Oral Intake of the Hypericum Perforatum Extract LI 160 in Healthy Volunteers

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1177/089198879400701S13

Identifiers

DOI

10.1177/026988110101500109

1 reference

30 July 2017

1 reference

PubMed ID

11277608